Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Evofem Biosciences, Inc. (EVFM : NSDQ)

• Company Description    Evofem Biosciences Inc. develops and anticipates commercializing products which support and promote women as the primary healthcare consumer. The company is identifying and developing new and novel products which specifically address unmet needs in the areas of sexual and reproductive health, the prevention of acquisition of sexually transmitted infections and products which address or promote general health and wellbeing. Evofem Biosciences Inc., formerly known as Neothetics Inc., is based in SAN DIEGO CA. Number of Employees: 119

• Price / Volume Information    Yesterday's Closing Price: $0.41 Daily Weekly Monthly 20 Day Moving Average: 1,573,829 shares Shares Outstanding: 12.15 (millions) Market Capitalization: $4.92 (millions) Beta: 0.02 52 Week High: $21.30 52 Week Low: $0.40 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -86.33% -85.03% 12 Week -94.37% -93.68% Year To Date -92.80% -91.21%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 12400 HIGH BLUFF DRIVE SUITE 600 - SAN DIEGO,CA 92130 USA ph: 858-550-1900 fax: 844-828-2010 araskopf@evofem.com http://www.evofem.com

• General Corporate Information    Officers Saundra Pelletier - President; Chief Executive Officer; and Interim Ch Justin J. File - Chief Financial Officer Gillian Greer - Director Kim P. Kamdar - Director Tony O'Brien - Director Peer Information Evofem Biosciences, Inc. (CORR.) Evofem Biosciences, Inc. (RSPI) Evofem Biosciences, Inc. (CGXP) Evofem Biosciences, Inc. (BGEN) Evofem Biosciences, Inc. (GTBP) Evofem Biosciences, Inc. (RGRX) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MED-BIOMED/GENE Sector: Medical CUSIP: 30048L203 SIC: 2834 Fiscal Year Fiscal Year End: December Last Reported Quarter: 03/01/22 Next Expected EPS Date: 08/10/22 Share - Related Items Shares Outstanding: 12.15 Most Recent Split Date: 5.00 (0.07:1) Beta: 0.02 Market Capitalization: $4.92 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $-2.51 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-9.06 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 3.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 08/10/22

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: - Price/Cash Flow: - Price / Sales: 0.43 EPS Growth vs. Year Ago Period: 65.70% vs. Previous Quarter: 41.79% Sales Growth vs. Year Ago Period: 284.71% vs. Previous Quarter: 19.08% ROE 03/31/22 - - 12/31/21 - - 09/30/21 - - ROA 03/31/22 - -254.96 12/31/21 - -225.13 09/30/21 - -173.58 Current Ratio 03/31/22 - 0.14 12/31/21 - 0.22 09/30/21 - 0.58 Quick Ratio 03/31/22 - 0.10 12/31/21 - 0.16 09/30/21 - 0.47 Operating Margin 03/31/22 - -1,417.24 12/31/21 - -2,131.09 09/30/21 - -3,402.13 Net Margin 03/31/22 - -1,676.29 12/31/21 - -2,488.99 09/30/21 - -4,011.48 Pre-Tax Margin 03/31/22 - -1,676.10 12/31/21 - -2,488.78 09/30/21 - -4,011.21 Book Value 03/31/22 - -10.54 12/31/21 - -9.59 09/30/21 - -5.68 Inventory Turnover 03/31/22 - 0.55 12/31/21 - 0.44 09/30/21 - 0.27 Debt-to-Equity 03/31/22 - - 12/31/21 - - 09/30/21 - - Debt-to-Capital 03/31/22 - - 12/31/21 - - 09/30/21 - -

Powered by Zacks Investment Research ©